In her first regular Patient Perspective column, which appears in the August issue of EP Lab Digest, StopAfib.org founder Mellanie True Hills explores a concern in the atrial fibrillation patient community that staying in afib long term could be a "death sentence." In addition, she talks about the upcoming National Atrial Fibrillation Awareness Month, which …
Read More
As a patient, you probably see lots of hype-filled reports about various drugs. After a drug is approved, there’s an inevitable blitz of negative publicity which often scares people away from important new solutions that could help them. There has been so much news lately about Multaq (dronedarone), the drug designed to provide the benefits …
Read More
The US FDA has just announced that on September 8, 2011, the FDA Cardiovascular and Renal Drugs Advisory Committee will meet to review whether to recommend approval of rivaroxaban (brand name Xarelto), an alternative to warfarin, for stroke prevention in atrial fibrillation. In this recent video interview, Dr. Elaine Hylek, a leading anticoagulant authority, discussed …
Read More
Recently StopAfib.org partnered with the Cleveland Clinic to give you a rare opportunity to chat live with three of their atrial fibrillation experts, Dr. Bruce Lindsay, Dr. Marc Gillinov, and Dr. David Van Wagoner who were joined by StopAfib.org founder Mellanie True Hills. The transcript of our afib community chat with these atrial fibrillation experts …
Read More
While catheter ablation has been proven more effective at stopping atrial fibrillation than antiarrhythmic drugs, pulmonary veins may reconnect and atrial fibrillation may return, causing the catheter ablation to fail. At the recent Heart Rhythm Society meeting, Dr. Vivek Reddy, Director of Cardiac Arrhythmia Services at Mt. Sinai Hospital in New York City, presented clinical …
Read More
Data presented at the recent 2011 Heart Rhythm Society meeting in San Francisco regarding the effectiveness of catheter ablation for treatment of persistent atrial fibrillation suggests that multiple procedures may be needed. Dr. Thomas Rostock presented data on 395 patients (261 with persistent atrial fibrillation and 134 with longstanding persistent afib) who had stepwise ablation …
Read More
In celebration of Stroke Awareness Month (May), atrial fibrillation patient advocacy organization StopAfib.org is pleased to announce the addition of four afib experts to our Global Medical Advisory Board. The board is now made up of 23 of the world's foremost electrophysiologists, surgeons, cardiologists, neurologists, epidemiologists, and researchers, all of whom are on the forefront …
Read More
In this video interview, Dr. Hugh Calkins, electrophysiologist at Johns Hopkins, talks about the effort underway to rewrite the HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation. The new global guidelines are expected in January of 2012. Watch the video at: Johns Hopkins Electrophysiologist, Dr. Hugh Calkins, On Updating the Atrial …
Read More
Atrial fibrillation is the most common irregular heart rhythm that starts in the atria. While it is often a mere annoyance, it can also be responsible for life-threatening medical emergencies that result in cardiac arrest, stroke and sudden death. Take advantage of this rare opportunity to chat live on June 13 with atrial fibrillation experts …
Read More
When the leading man in her life was diagnosed with atrial fibrillation (afib), actress Susan Lucci jumped into action and pledged to learn everything she could about his condition. Now she and her husband, Helmut Huber, ask you to join them in taking the Facing AFib Pledge to learn more about atrial fibrillation, partner with …
Read More